One manufacturer has problems...no surprise that the cost is going up....the law of cause and effect I guess...and maybe someone has to pay for the extra time involvement of the FDA somewhere along the line? BD
NEW YORK (Reuters) May 15 - APP Pharmaceuticals Inc, the main supplier of the blood thinner heparin to the U.S. market in the wake of a contamination scandal, said on Thursday it was raising prices because of higher costs for raw materials, additional testing and labor.
APP also said it had completed testing on all lots of its heparin raw material dating back to January 2006 and had found all products to be contaminant-free. The U.S. Food and Drug Administration has also tested select material from APP samples and reviewed its analytical results, confirming the purity of its heparin, the company said.
0 comments :
Post a Comment